• Therapeutic Areas/ 
  • Rheumatology


Piroxicam-beta-cyclodextrin is a molecule developed by Chiesi, based on a chemical complex created by host-guest technology, in which each molecule of piroxicam is coated with a molecule of starch. This formulation leads to significantly improved resorption and thus to a much faster onset of analgesic action. The portfolio contains also Orthokine-autologus treatment of osteoarthritis (Orthokine®).

  • Orthokine
  • Piroxicam betadex cyclodextrin

Product informations are intended for health care professionals. For complete prescribing informations please refer to the summary of Product Characteristics on http://www.anm.ro/anm/anm_list.asp or consult your pharmacist or doctor for further details regarding our products.